Review and re-appraisal of patients treated with splenectomy for immune thrombocytopenic purpura at five years and beyond
Master Thesis
2002
Permanent link to this Item
Authors
Supervisors
Journal Title
Link to Journal
Journal ISSN
Volume Title
Publisher
Publisher
University of Cape Town
Department
Faculty
License
Series
Abstract
The risk of pneumococcal infection post splenectomy is life long so all patients undergoing splenectomy are given polyvalent (23-valent) unconjugated pneumococcal polysaccharide vaccine, preoperatively. The aim of this study was 1. to measure the success of splenectomy at a tertiary institution at 5 years and beyond. 2. To review the incidence of complications peri-operatively and long term. 3. Review the need for possible re-vaccination (as recommended in American and British guidelines and 4. perform a re-appraisal of patients found to be refractory to treatment.
Description
Includes bibliographical references.
Keywords
Reference:
Seth, Y. 2002. Review and re-appraisal of patients treated with splenectomy for immune thrombocytopenic purpura at five years and beyond. University of Cape Town.